Salivary cortisol and DHEA: association with measures of cognition and well-being in normal older men, and effects of three months of DHEA supplementation

Dehydroepiandrosterone (DHEA) is a steroid that shows a marked age-related decline in humans. Previous research suggests potential for DHEA replacement in old age to enhance cognition and well-being. We conducted a clinical trial to test these hypotheses in a non-clinical sample of 46 men aged 62-76. Participants received either 50 mg DHEA daily for 13 weeks, followed by placebo for 13 weeks, or the reverse, in a randomised double-blind cross-over trial design. Levels of salivary cortisol and DHEA were measured at 0800 h and 2000 h prior to each assessment session. Cognition was assessed with tests of speed, attention and episodic memory. Well-being was measured with questionnaires of mood and perceived health. Mood questionnaires were completed at the assessment session as well as concurrently with saliva sampling.A correlational analysis of baseline behavioural data with hormonal data, controlling for age, revealed that higher morning DHEA was associated with lower confusion (r=-0.33; P=0.04), while higher evening DHEA was associated with lower anxiety (r=-0.35; P=0.03) and lower current negative mood in the morning (r=-0.37; P=0.03). Conversely, higher morning cortisol and a morning cortisol/DHEA ratio were associated with higher anxiety (r=0.35; P=0.03), (r=0.46; P=0.004), general mood disturbance (r=0.32; P=0.046), (r=0.32; P=0.04) and higher current negative mood in the evening (r=0.37; P=0.03), (r=0.38; P=0.03). A higher morning cortisol/DHEA ratio was also associated with higher confusion (r=0.39; P=0.01) and lower visuo-spatial memory performance (r=-0.39; P=0.01). Unexpectedly, higher evening cortisol was associated with faster choice reaction time (r=-0.33; P=0.04). These findings are consistent with an impairing effect of high cortisol on episodic memory and mood in older men, which may be attenuated by DHEA. When treatment effects were analysed, no significant effects of DHEA were observed on any of the trial outcomes, providing no support for benefits of DHEA supplementation for cognition or well-being in normal older men in the shorter-term.

[1]  J. Rabkin,et al.  DHEA treatment for HIV+ patients: effects on mood, androgenic and anabolic parameters , 2000, Psychoneuroendocrinology.

[2]  O. Wolf,et al.  Actions of dehydroepiandrosterone and its sulfate in the central nervous system: effects on cognition and emotion in animals and humans , 1999, Brain Research Reviews.

[3]  O. Wolkowitz,et al.  Antiglucocorticoid treatments in psychiatry , 1997, Psychoneuroendocrinology.

[4]  M. May,et al.  Protection from glucocorticoid induced thymic involution by dehydroepiandrosterone. , 1990, Life sciences.

[5]  K. Barnhart,et al.  The effect of deydroepiandrosterone supplementation to symptomatic perimenopausal women on serum endocrine profiles, lipid parameters, and health-related quality of life , 1999 .

[6]  C. Jenkinson,et al.  Assessment of the SF-36 version 2 in the United Kingdom. , 1999, Journal of epidemiology and community health.

[7]  E. Baulieu,et al.  Dehydroepiandrosterone (DHEA), DHEA sulfate, and aging: contribution of the DHEAge Study to a sociobiomedical issue. , 2000 .

[8]  A. Hofman,et al.  A prospective study on cortisol, dehydroepiandrosterone sulfate, and cognitive function in the elderly. , 1998, The Journal of clinical endocrinology and metabolism.

[9]  Michael A. Andrykowski,et al.  Short Form of the Profile of Mood States (POMS-SF): Psychometric Information. , 1995 .

[10]  L. Squire Memory and the hippocampus: a synthesis from findings with rats, monkeys, and humans. , 1992, Psychological review.

[11]  E. Bernton,et al.  Dehydroepiandrosterone antagonizes the suppressive effects of dexamethasone on lymphocyte proliferation. , 1991, Endocrinology.

[12]  D. Kuh,et al.  Lifetime cognitive function and timing of the natural menopause , 1999, Neurology.

[13]  D. Jakubowicz,et al.  Disparate effects of weight reduction by diet on serum dehydroepiandrosterone-sulfate levels in obese men and women. , 1995, The Journal of clinical endocrinology and metabolism.

[14]  Schwartz,et al.  Basal cortisol levels and cognitive deficits in human aging , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[15]  Dehydroepiandrosterone replacement in women with adrenal insufficiency. , 1999 .

[16]  M. Majewska,et al.  Neuronal Actions of Dehydroepiandrosterone Possible Roles in Brain Development, Aging, Memory, and Affect , 1995, Annals of the New York Academy of Sciences.

[17]  S. Shacham,et al.  A shortened version of the Profile of Mood States. , 1983, Journal of personality assessment.

[18]  M. Bidlingmaier,et al.  Dehydroepiandrosterone replacement in women with adrenal insufficiency. , 1999, The New England journal of medicine.

[19]  E. Barrett-Connor,et al.  Endogenous Levels of Dehydroepiandrosterone Sulfate, but Not Other Sex Hormones, Are Associated with Depressed Mood in Older Women: The Rancho Bernardo Study , 1999, Journal of the American Geriatrics Society.

[20]  Denise C. Park,et al.  Cognitive Aging: A Primer , 1999 .

[21]  S. Yen,et al.  Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age. , 1994, The Journal of clinical endocrinology and metabolism.

[22]  B. Kudielka,et al.  Sex differences in endocrine and psychological responses to psychosocial stress in healthy elderly subjects and the impact of a 2-week dehydroepiandrosterone treatment. , 1998, The Journal of clinical endocrinology and metabolism.

[23]  M. Barry,et al.  The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association. , 1992, The Journal of urology.

[24]  C. Montigny,et al.  Potentiation by dehydroepiandrosterone of the neuronal response to N-methyl-D-aspartate in the CA3 region of the rat dorsal hippocampus: an effect mediated via sigma receptors. , 1996, The Journal of endocrinology.

[25]  I. Goodyer,et al.  Cortisol, dehydroepiandrosterone (DHEA), and DHEA sulfate in the cerebrospinal fluid of man: relation to blood levels and the effects of age. , 1996, The Journal of clinical endocrinology and metabolism.

[26]  A. Convit,et al.  Cortisol levels during human aging predict hippocampal atrophy and memory deficits , 1998, Nature Neuroscience.

[27]  R. Kronmal Spurious Correlation and the Fallacy of the Ratio Standard Revisited , 1993 .

[28]  J. Born,et al.  Corticosteroid receptor mediated effects on mood in humans , 1996, Psychoneuroendocrinology.

[29]  L. Carlson,et al.  Relationships among cortisol (CRT), dehydroepiandrosterone-sulfate (DHEAS), and memory in a longitudinal study of healthy elderly men and women , 1999, Neurobiology of Aging.

[30]  C. Kirschbaum,et al.  Effects of a two-week physiological dehydroepiandrosterone substitution on cognitive performance and well-being in healthy elderly women and men. , 1997, The Journal of clinical endocrinology and metabolism.

[31]  F. Huppert,et al.  Improvement in mood and fatigue after dehydroepiandrosterone replacement in Addison's disease in a randomized, double blind trial. , 2000, The Journal of clinical endocrinology and metabolism.

[32]  J. Poirier,et al.  Dehydroepiandrosterone (DHEA) protects hippocampal cells from oxidative stress-induced damage. , 1999, Brain research. Molecular brain research.

[33]  R. Petersen,et al.  Development of Cognitive Instruments for Use in Clinical Trials of Antidementia Drugs: Additions to the Alzheimer's Disease Assessment Scale That Broaden Its Scope , 1997, Alzheimer disease and associated disorders.

[34]  E. Browne,et al.  Antiglucocorticoid action of dehydroepiandrosterone in young obese Zucker rats. , 1992, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity.

[35]  W. Regelson,et al.  Dehydroepiandrosterone prevents dexamethasone-induced hypertension in rats. , 1992, The American journal of physiology.

[36]  B. Allolio,et al.  Biotransformation of oral dehydroepiandrosterone in elderly men: significant increase in circulating estrogens. , 1999, The Journal of clinical endocrinology and metabolism.

[37]  C. Kirschbaum,et al.  Effects of dehydroepiandrosterone replacement in elderly men on event-related potentials, memory, and well-being. , 1998, The journals of gerontology. Series A, Biological sciences and medical sciences.

[38]  P. Zimmet,et al.  5 The epidemiology of obesity , 1994 .

[39]  C. Montigny,et al.  Potentiation of neuronal NMDA response induced by dehydroepiandrosterone and its suppression by progesterone: effects mediated via sigma receptors , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[40]  T. Maurice,et al.  Neuroprotective and anti-amnesic potentials of sigma (σ) receptor ligands , 1997, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[41]  J. Dartigues,et al.  Relationships of dehydroepiandrosterone sulfate in the elderly with functional, psychological, and mental status, and short-term mortality: a French community-based study. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[42]  E. Barrett-Connor,et al.  A Prospective Study of Dehydroepiandrosterone Sulfate and Cognitive Function in an Older Population: The Rancho Bernardo Study , 1994, Journal of the American Geriatrics Society.

[43]  F. Huppert,et al.  The health and lifestyle survey : seven years on , 1993 .

[44]  J. Herbert,et al.  Fortnightly review: Stress, the brain, and mental illness , 1997, BMJ.

[45]  J. Bancroft,et al.  Steroid hormones, the menopause, sexuality and well-being of women , 1996, Psychological Medicine.

[46]  M. Flynn,et al.  Dehydroepiandrosterone replacement in aging humans. , 1999, The Journal of clinical endocrinology and metabolism.

[47]  O. Wolkowitz,et al.  Double-blind treatment of major depression with dehydroepiandrosterone. , 1999, The American journal of psychiatry.

[48]  A. Booth,et al.  Assessing dehydroepiandrosterone in saliva: a simple radioimmunoassay for use in studies of children, adolescents and adults , 1999, Psychoneuroendocrinology.

[49]  J. Dmochowski,et al.  Influence of family history on clinical expression of Tourette’s syndrome , 1999, Neurology.

[50]  R. Sapolsky Why Stress Is Bad for Your Brain , 1996, Science.

[51]  M. Albert,et al.  Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1997 by The Endocrine Society Increase in Urinary Cortisol Excretion and Memory Declines: MacArthur Studies of Successful Aging* , 2022 .

[52]  N. Orentreich,et al.  Long-term longitudinal measurements of plasma dehydroepiandrosterone sulfate in normal men. , 1992, The Journal of clinical endocrinology and metabolism.

[53]  K. Yaffe,et al.  Neuropsychiatric Function and Dehydroepiandrosterone Sulfate in Elderly Women: A Prospective Study , 1998, Biological Psychiatry.

[54]  D. Rubinow,et al.  Dehydroepiandrosterone treatment of midlife dysthymia∗ ∗ See accompanying Editorial, in this issue. , 1999, Biological Psychiatry.

[55]  S. Yen,et al.  Replacement of DHEA in Aging Men and Women , 1995, Annals of the New York Academy of Sciences.

[56]  Dirk H. Hellhammer,et al.  OPPOSING EFFECTS OF DHEA REPLACEMENT IN ELDERLY SUBJECTS ON DECLARATIVE MEMORY AND ATTENTION AFTER EXPOSURE TO A LABORATORY STRESSOR , 1998, Psychoneuroendocrinology.

[57]  M. Lorr,et al.  Manual for the Profile of Mood States , 1971 .

[58]  E. Diener,et al.  The independence of positive and negative affect. , 1984, Journal of personality and social psychology.

[59]  C. Keen,et al.  Zinc status in human immunodeficiency virus infection. , 1990, Life sciences.

[60]  Douglas G. Altman,et al.  Practical statistics for medical research , 1990 .

[61]  W. Regelson,et al.  Dehydroepiandrosterone protects hippocampal neurons against neurotoxin-induced cell death: mechanism of action. , 1999, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[62]  M. Sofroniew,et al.  Dehydroepiandrosterone (DHEA) and DHEA-sulfate (DHEAS) protect hippocampal neurons against excitatory amino acid-induced neurotoxicity. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[63]  N Butters,et al.  Detection of abnormal memory decline in mild cases of Alzheimer's disease using CERAD neuropsychological measures. , 1991, Archives of neurology.

[64]  J. Fawcett,et al.  Dehydroepiandrosterone antagonizes the neurotoxic effects of corticosterone and translocation of stress-activated protein kinase 3 in hippocampal primary cultures , 1999, Neuroscience.

[65]  I. Goodyer,et al.  Adrenal secretion during major depression in 8- to 16-year-olds, I. Altered diurnal rhythms in salivary cortisol and dehydroepiandrosterone (DHEA) at presentation , 1996, Psychological Medicine.